<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: The goal of the present study was to examine a series of putative risk factors of poststroke <z:hpo ids='HP_0000726'>dementia</z:hpo> (PSD), especially those factors usually associated with cerebrovascular disease and degenerative <z:hpo ids='HP_0000726'>dementia</z:hpo>, in a series of 251 consecutive unselected <z:hpo ids='HP_0001297'>stroke</z:hpo> patients </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A standard protocol was prospectively applied at admission and 3 months after <z:hpo ids='HP_0001297'>stroke</z:hpo>; this protocol included clinical, functional, and cognitive assessments, hemogram and serum biochemistry, ECG and CT exams, <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E and angiotensin-converting enzyme genotype, and neuropsychological examination </plain></SENT>
<SENT sid="2" pm="."><plain>After a neuropsychological examination and an interview with a relative, the following diagnostic criteria were used: the Diagnostic and Statistical Manual of <z:e sem="disease" ids="C0004936" disease_type="Mental or Behavioral Dysfunction" abbrv="">Mental Disorders</z:e> (<z:chebi fb="4" ids="38624">DSM</z:chebi>)-IV for <z:hpo ids='HP_0000726'>dementia</z:hpo> after <z:hpo ids='HP_0001297'>stroke</z:hpo>, <z:chebi fb="4" ids="38624">DSM</z:chebi>-III-R for previous <z:hpo ids='HP_0000726'>dementia</z:hpo> and <z:hpo ids='HP_0000726'>dementia</z:hpo> stage, and Association Internationale pour la Recherche et l'Enseignement en Neurologie (NINDS-AIREN) for vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Seventy-five cases (30%) demonstrated <z:hpo ids='HP_0000726'>dementia</z:hpo> at 3-month follow up; 25 of them (10%) had demonstrated <z:hpo ids='HP_0000726'>dementia</z:hpo> before the <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000726'>Dementia</z:hpo> was unrelated to type (ischemic/hemorrhagic) or location of <z:hpo ids='HP_0001297'>stroke</z:hpo>, vascular factors (<z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e>, or <z:hpo ids='HP_0003124'>hypercholesterolemia</z:hpo>), <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E or angiotensin-converting enzyme genotype, and serum <z:chebi fb="0" ids="17230">homocysteine</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>Age (odds ratio [OR] 1.1, 95% CI 1.03 to 1.2), previous <z:hpo ids='HP_0000112'>nephropathy</z:hpo> (OR 6.1, 95% CI 1.5 to 24.3), <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> (OR 4.4, 95% CI 1 </plain></SENT>
<SENT sid="6" pm="."><plain>4 to 13.9), low Canadian Neurological Scale score at discharge (OR 0 </plain></SENT>
<SENT sid="7" pm="."><plain>5, 95% CI 0.4 to 0.6), and previous mental decline assessed by the shortened Spanish version of the Informant Questionnaire on <z:hpo ids='HP_0001268'>Cognitive Decline</z:hpo> in the Elderly (SS-IQCODE; OR 1.2, 95% CI 1.1 to 1 </plain></SENT>
<SENT sid="8" pm="."><plain>4) were the correlates of <z:hpo ids='HP_0000726'>dementia</z:hpo> in logistic regression analyses </plain></SENT>
<SENT sid="9" pm="."><plain>The same risks factors were found when cases with previous <z:hpo ids='HP_0000726'>dementia</z:hpo> and with hemorrhagic <z:hpo ids='HP_0001297'>stroke</z:hpo> were excluded </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: <z:hpo ids='HP_0000726'>Dementia</z:hpo> is frequent after ischemic or hemorrhagic <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>Age, <z:hpo ids='HP_0000112'>nephropathy</z:hpo>, <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo>, previous mental decline, and <z:hpo ids='HP_0001297'>stroke</z:hpo> severity independently contribute to the risk </plain></SENT>
</text></document>